Anika Therapeutics, Inc. (ANIK) Tops Q2 EPS by 3c, Revenue Light
Get Alerts ANIK Hot Sheet
Price: $25.90 --0%
EPS Growth %: -63.6%
Financial Fact:
Total operating expenses: 12.1M
Today's EPS Names:
UXIN, TOWN, NRIM, More
EPS Growth %: -63.6%
Financial Fact:
Total operating expenses: 12.1M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q2 EPS of $0.60, $0.03 better than the analyst estimate of $0.57. Revenue for the quarter came in at $26.3 million versus the consensus estimate of $28.2 million.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Berenberg Starts Lloyds TSB Group (LYG) at Hold, 'shares are fairly valued'
- Meta Platforms Inc. (META) PT Raised to $510 at Roth/MKM, 'Buy On Weakness; AI Moat Now Deeper'
- Meta earnings, IBM to acquire HashiCorp, U.S. GDP ahead - what's moving markets
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!